CTEV
Claritev Corporation
NYSE: CTEV · HEALTHCARE · HEALTH INFORMATION SERVICES
$24.33
+5.51% today
Updated 2026-04-30
Market cap
$403.98M
P/E ratio
—
P/S ratio
0.42x
EPS (TTM)
$-17.30
Dividend yield
—
52W range
$12 – $74
Volume
0.2M
Claritev Corporation (CTEV) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | — | $8.36B | $8.28B | $8.22B | $7.37B | $6.96B | $5.15B |
| Cash & equivalents | — | $21.82M | $126.75M | $185.33M | $334.05M | $71.55M | $16.85M |
| Current assets | — | $115.61M | $208.85M | $319.26M | $446.74M | $193.59M | $175.51M |
| Total liabilities | — | $6.38B | $5.73B | $5.88B | $5.58B | $5.26B | $5.07B |
| Current liabilities | — | $85.79M | $112.50M | $141.91M | $175.84M | $166.74M | $213.79M |
| Long-term debt | — | — | — | $4.88B | $4.74B | $4.53B | $4.51B |
| Shareholder equity | — | $1.99B | $2.56B | $2.34B | $1.79B | $1.71B | $84.02M |
| Retained earnings | — | $637.56M | $117.00M | $225.11M | $-347.80M | $-499.31M | $-2.15B |
| Accounts receivable | — | $77.07M | $63.20M | $99.91M | $78.91M | $84.75M | $111.61M |
| Inventory | — | — | — | — | — | — | — |
| Goodwill | — | $4.14B | $4.26B | $4.36B | $3.71B | $3.83B | $2.40B |